Insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Pandion Therapeutics, Inc. (PAND) since 2020 are shown in Table 1 and Table 2. Table 1 shows the monthly insider trading data of Pandion Therapeutics, Inc.. Table 2 shows the detailed insider transactions. This company's CIK number is 1807901.
Total stock buying since 2020: $65,528,995.
Total stock sales since 2020: $0.
Total stock option exercises since 2020: $0.
| Insider Buying | Insider Sales | Option Exercises | ||||
|---|---|---|---|---|---|---|
| Year | Shares | Value | Shares | Value | Shares | Value |
| 2020 | 3,676,803 | $65,528,995 | 0 | $0 | 0 | $0 |
| Trading Period | Insider Buying | Insider Sales | Option Exercises | |||
|---|---|---|---|---|---|---|
| year-month | Shares | Value | Shares | Value | Shares | Value |
| 2020-11 | 227,110 | $3,434,521 | 0 | $0 | 0 | $0 |
| 2020-07 | 3,449,693 | $62,094,474 | 0 | $0 | 0 | $0 |
| Trade Date | Insider Name | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2020-11-19 | Becker Daniel J. (Director) | Buy | 197,716 | 15.12 | 2,989,465 |
| 2020-11-18 | Becker Daniel J. (Director) | Buy | 14,197 | 15.26 | 216,646 |
| 2020-11-17 | Becker Daniel J. (Director) | Buy | 15,197 | 15.03 | 228,410 |
| 2020-07-21 | Mutz Mitchell (Director) | Buy | 46,111 | 18.00 | 829,998 |
| 2020-07-21 | Frail Donald (Director) | Buy | 10,000 | 18.00 | 180,000 |
| 2020-07-21 | Stagliano Nancy (Director) | Buy | 1,000 | 18.00 | 18,000 |
| 2020-07-21 | Kakkar Rahul (Chief Executive Officer) | Buy | 14,000 | 18.00 | 252,000 |
| 2020-07-21 | Sundy John (Chief Medical Officer) | Buy | 2,000 | 18.00 | 36,000 |
| 2020-07-21 | Viney Joanne L. (See Remarks) | Buy | 1,200 | 18.00 | 21,600 |
| 2020-07-21 | Becker Daniel J. (Director) | Buy | 723,222 | 18.00 | 13,017,996 |
| 2020-07-21 | Goyal Vikas (See Remarks) | Buy | 1,450 | 18.00 | 26,100 |
| 2020-07-21 | Larson Eric D (Vice President, Finance) | Buy | 600 | 18.00 | 10,800 |
| 2020-07-21 | Polaris Partners Viii, L.p. (10% Owner) | Buy | 36,111 | 18.00 | 649,998 |
| 2020-07-21 | Shah Rajeev M. | Buy | 361,111 | 18.00 | 6,499,998 |
| 2020-07-21 | Carroll Jill (Director) | Buy | 361,111 | 18.00 | 6,499,998 |
| 2020-07-21 | Mva Investors, Llc (10% Owner) | Buy | 722,222 | 18.00 | 12,999,996 |
| 2020-07-21 | Fuglesang Christopher (Director) | Buy | 722,222 | 18.00 | 12,999,996 |
| 2020-07-21 | Crane Alan L (Director) | Buy | 50,111 | 18.00 | 901,998 |
| 2020-07-21 | Glaxosmithkline Plc | Buy | 361,111 | 18.00 | 6,499,998 |
| 2020-07-21 | Roche Finance Ltd (10% Owner) | Buy | 36,111 | 18.00 | 649,998 |
Insider trading activities including stock purchases, stock sales, and option exercises of PAND listed in the above tables cannot be completely guaranteed as to their accuracy. For more insider trading information of Pandion Therapeutics, Inc. (symbol PAND, CIK number 1807901) see the Securities and Exchange Commission (SEC) website.